• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

食管癌中针对癌症干细胞的治疗策略

Therapeutic Strategies Against Cancer Stem Cells in Esophageal Carcinomas.

作者信息

Das Plabon Kumar, Islam Farhadul, Smith Robert A, Lam Alfred K

机构信息

Department of Biochemistry and Molecular Biology, University of Rajshahi, Rajshahi, Bangladesh.

Institute for Glycomics, Griffith University, Gold Coast, QLD, Australia.

出版信息

Front Oncol. 2021 Feb 16;10:598957. doi: 10.3389/fonc.2020.598957. eCollection 2020.

DOI:10.3389/fonc.2020.598957
PMID:33665161
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7921694/
Abstract

Cancer stem cells (CSCs) in esophageal cancer have a key role in tumor initiation, progression and therapy resistance. Novel therapeutic strategies to target CSCs are being tested, however, more in-depth research is necessary. Eradication of CSCs can result in successful therapeutic approaches against esophageal cancer. Recent evidence suggests that targeting signaling pathways, miRNA expression profiles and other properties of CSCs are important strategies for cancer therapy. Wnt/β-catenin, Notch, Hedgehog, Hippo and other pathways play crucial roles in proliferation, differentiation, and self-renewal of stem cells as well as of CSCs. All of these pathways have been implicated in the regulation of esophageal CSCs and are potential therapeutic targets. Interference with these pathways or their components using small molecules could have therapeutic benefits. Similarly, miRNAs are able to regulate gene expression in esophageal CSCs, so targeting self-renewal pathways with miRNA could be utilized to as a potential therapeutic option. Moreover, hypoxia plays critical roles in esophageal cancer metabolism, stem cell proliferation, maintaining aggressiveness and in regulating the metastatic potential of cancer cells, therefore, targeting hypoxia factors could also provide effective therapeutic modalities against esophageal CSCs. To conclude, additional study of CSCs in esophageal carcinoma could open promising therapeutic options in esophageal carcinomas by targeting hyper-activated signaling pathways, manipulating miRNA expression and hypoxia mechanisms in esophageal CSCs.

摘要

食管癌中的癌症干细胞(CSCs)在肿瘤起始、进展和治疗抵抗中起关键作用。针对CSCs的新型治疗策略正在进行测试,然而,仍需要更深入的研究。根除CSCs可带来针对食管癌的成功治疗方法。最近的证据表明,靶向CSCs的信号通路、miRNA表达谱和其他特性是癌症治疗的重要策略。Wnt/β-连环蛋白、Notch、Hedgehog、Hippo等通路在干细胞以及CSCs的增殖、分化和自我更新中起关键作用。所有这些通路都与食管CSCs的调控有关,并且是潜在的治疗靶点。使用小分子干扰这些通路或其组成部分可能具有治疗益处。同样,miRNAs能够调节食管CSCs中的基因表达,因此用miRNA靶向自我更新通路可作为一种潜在的治疗选择。此外,缺氧在食管癌代谢、干细胞增殖、维持侵袭性以及调节癌细胞的转移潜能中起关键作用,因此,靶向缺氧因子也可为针对食管CSCs提供有效的治疗方式。总之,对食管癌中CSCs的进一步研究可能通过靶向食管CSCs中过度激活的信号通路、操纵miRNA表达和缺氧机制,为食管癌开辟有前景的治疗选择。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f40/7921694/a3042a6d6d54/fonc-10-598957-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f40/7921694/9cc14545991c/fonc-10-598957-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f40/7921694/85acca2510e9/fonc-10-598957-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f40/7921694/a3042a6d6d54/fonc-10-598957-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f40/7921694/9cc14545991c/fonc-10-598957-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f40/7921694/85acca2510e9/fonc-10-598957-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f40/7921694/a3042a6d6d54/fonc-10-598957-g003.jpg

相似文献

1
Therapeutic Strategies Against Cancer Stem Cells in Esophageal Carcinomas.食管癌中针对癌症干细胞的治疗策略
Front Oncol. 2021 Feb 16;10:598957. doi: 10.3389/fonc.2020.598957. eCollection 2020.
2
Linking Cancer Stem Cell Plasticity to Therapeutic Resistance-Mechanism and Novel Therapeutic Strategies in Esophageal Cancer.将癌症干细胞可塑性与治疗抵抗机制相关联——食管癌的治疗策略新方向。
Cells. 2020 Jun 17;9(6):1481. doi: 10.3390/cells9061481.
3
Natural compounds as a potential modifier of stem cells renewal: Comparative analysis.天然化合物作为干细胞更新的潜在修饰物:比较分析。
Eur J Pharmacol. 2023 Jan 5;938:175412. doi: 10.1016/j.ejphar.2022.175412. Epub 2022 Nov 24.
4
The Roles of Cancer Stem Cells and Therapy Resistance in Colorectal Carcinoma.癌症干细胞与结直肠癌耐药的关系
Cells. 2020 Jun 3;9(6):1392. doi: 10.3390/cells9061392.
5
Breast cancer stem cells and the challenges of eradication: a review of novel therapies.乳腺癌干细胞与根除挑战:新型疗法综述
Stem Cell Investig. 2018 Oct 31;5:39. doi: 10.21037/sci.2018.10.05. eCollection 2018.
6
Hypoxia inducible factors in the tumor microenvironment as therapeutic targets of cancer stem cells.肿瘤微环境中的缺氧诱导因子作为癌症干细胞的治疗靶点。
Life Sci. 2019 Nov 15;237:116952. doi: 10.1016/j.lfs.2019.116952. Epub 2019 Oct 14.
7
Dissecting Tumor Growth: The Role of Cancer Stem Cells in Drug Resistance and Recurrence.剖析肿瘤生长:癌症干细胞在耐药性和复发中的作用
Cancers (Basel). 2022 Feb 15;14(4):976. doi: 10.3390/cancers14040976.
8
miRNA-regulated delivery of lincRNA-p21 suppresses β-catenin signaling and tumorigenicity of colorectal cancer stem cells.微小RNA调控的长链非编码RNA-p21传递可抑制β-连环蛋白信号通路及结直肠癌干细胞的致瘤性。
Oncotarget. 2015 Nov 10;6(35):37852-70. doi: 10.18632/oncotarget.5635.
9
Regulation of Metabolic Plasticity in Cancer Stem Cells and Implications in Cancer Therapy.癌症干细胞中代谢可塑性的调控及其在癌症治疗中的意义
Cancers (Basel). 2022 Nov 30;14(23):5912. doi: 10.3390/cancers14235912.
10
Cancer stem cells (CSCs) in cancer progression and therapy.癌症进展和治疗中的癌症干细胞 (CSCs)。
J Cell Physiol. 2019 Jun;234(6):8381-8395. doi: 10.1002/jcp.27740. Epub 2018 Nov 11.

引用本文的文献

1
Overexpression of KRAS enhanced the stemness of esophageal cancer cells inhibited by overexpression of circ0043898.KRAS的过表达增强了被circ0043898过表达抑制的食管癌细胞的干性。
BMC Cancer. 2025 Jul 1;25(1):1039. doi: 10.1186/s12885-025-14358-8.
2
From bench to bedside: the role of gastrointestinal stem cells in health and disease.从实验室到临床:胃肠道干细胞在健康与疾病中的作用
Inflamm Regen. 2025 May 28;45(1):15. doi: 10.1186/s41232-025-00378-1.
3
Pharmacological Modulation of Mutant with Oncotargets Against Esophageal Cancer and Therapy Resistance.

本文引用的文献

1
Linking Cancer Stem Cell Plasticity to Therapeutic Resistance-Mechanism and Novel Therapeutic Strategies in Esophageal Cancer.将癌症干细胞可塑性与治疗抵抗机制相关联——食管癌的治疗策略新方向。
Cells. 2020 Jun 17;9(6):1481. doi: 10.3390/cells9061481.
2
The Roles of Cancer Stem Cells and Therapy Resistance in Colorectal Carcinoma.癌症干细胞与结直肠癌耐药的关系
Cells. 2020 Jun 3;9(6):1392. doi: 10.3390/cells9061392.
3
Detention and Identification of Cancer Stem Cells in Esophageal Squamous Cell Carcinoma.食管鳞癌中癌症干细胞的滞留与鉴定。
针对食管癌和治疗耐药性的癌基因靶点对突变体的药理学调控
Biomedicines. 2025 Feb 12;13(2):450. doi: 10.3390/biomedicines13020450.
4
Superior Anticancer and Antifungal Activities of New Sulfanyl-Substituted Niclosamide Derivatives.新型硫烷基取代氯硝柳胺衍生物的卓越抗癌和抗真菌活性
Biomedicines. 2024 Jul 21;12(7):1621. doi: 10.3390/biomedicines12071621.
5
Causal relationship between gut microbiota and risk of esophageal cancer: evidence from Mendelian randomization study.肠道微生物群与食管癌风险的因果关系:来自孟德尔随机化研究的证据。
Aging (Albany NY). 2024 Feb 15;16(4):3596-3611. doi: 10.18632/aging.205547.
6
Microbiome changes in esophageal cancer: implications for pathogenesis and prognosis.食管癌的微生物组变化:对发病机制和预后的影响。
Cancer Biol Med. 2023 Oct 9;21(2):163-74. doi: 10.20892/j.issn.2095-3941.2023.0177.
7
A Review of Hedgehog Signaling in Radioresistant Esophageal Cancer: Potential Treatment Target.《 Hedgehog 信号通路在放射性抵抗食管鳞癌中的研究进展:潜在的治疗靶点》
Technol Cancer Res Treat. 2023 Jan-Dec;22:15330338231169873. doi: 10.1177/15330338231169873.
8
New 4,5-Diarylimidazol-2-ylidene-iodidogold(I) Complexes with High Activity against Esophageal Adenocarcinoma Cells.新型 4,5-二取代咪唑-2-亚基碘化金(I)复合物对食管腺癌细胞具有高活性。
Int J Mol Sci. 2023 Mar 17;24(6):5738. doi: 10.3390/ijms24065738.
9
A Gold Nanoparticle Bioconjugate Delivery System for Active Targeted Photodynamic Therapy of Cancer and Cancer Stem Cells.一种用于癌症和癌症干细胞主动靶向光动力治疗的金纳米颗粒生物共轭递送系统。
Cancers (Basel). 2022 Sep 20;14(19):4558. doi: 10.3390/cancers14194558.
10
CSMD1 Mutation Related to Immunity Can Be Used as a Marker to Evaluate the Clinical Therapeutic Effect and Prognosis of Patients with Esophageal Cancer.与免疫相关的CSMD1突变可作为评估食管癌患者临床治疗效果和预后的标志物。
Int J Gen Med. 2021 Nov 23;14:8689-8710. doi: 10.2147/IJGM.S338284. eCollection 2021.
Methods Mol Biol. 2020;2129:177-191. doi: 10.1007/978-1-0716-0377-2_14.
4
miR-135a Inhibits the Invasion and Migration of Esophageal Cancer Stem Cells through the Hedgehog Signaling Pathway by Targeting Smo.微小RNA-135a通过靶向Smoothened蛋白经刺猬信号通路抑制食管癌干细胞的侵袭与迁移。
Mol Ther Nucleic Acids. 2020 Mar 6;19:841-852. doi: 10.1016/j.omtn.2019.10.037. Epub 2019 Nov 13.
5
Plasticity of Cancer Stem Cell: Origin and Role in Disease Progression and Therapy Resistance.癌症干细胞可塑性:起源及其在疾病进展和治疗耐药中的作用。
Stem Cell Rev Rep. 2020 Apr;16(2):397-412. doi: 10.1007/s12015-019-09942-y.
6
Novel Therapeutics Against Breast Cancer Stem Cells by Targeting Surface Markers and Signaling Pathways.通过靶向表面标志物和信号通路对抗乳腺癌干细胞的新型疗法
Curr Stem Cell Res Ther. 2019;14(8):669-682. doi: 10.2174/1574888X14666190628104721.
7
MicroRNAs, a Promising Target for Breast Cancer Stem Cells.微小 RNA,乳腺癌干细胞的有前途的靶点。
Mol Diagn Ther. 2020 Feb;24(1):69-83. doi: 10.1007/s40291-019-00439-5.
8
Downregulation of AAA-domain-containing protein 2 restrains cancer stem cell properties in esophageal squamous cell carcinoma via blockade of the Hedgehog signaling pathway.下调 AAA 结构域蛋白 2 通过阻断 Hedgehog 信号通路抑制食管鳞癌细胞中的癌症干细胞特性。
Am J Physiol Cell Physiol. 2020 Jul 1;319(1):C93-C104. doi: 10.1152/ajpcell.00133.2019. Epub 2019 Nov 20.
9
Role of the NF-κB signaling pathway in the pathogenesis of colorectal cancer.NF-κB 信号通路在结直肠癌发病机制中的作用。
Gene. 2020 Feb 5;726:144132. doi: 10.1016/j.gene.2019.144132. Epub 2019 Dec 3.
10
Cancer stem cells in esophageal squamous cell cancer.食管鳞状细胞癌中的癌症干细胞。
Oncol Lett. 2019 Nov;18(5):5022-5032. doi: 10.3892/ol.2019.10900. Epub 2019 Sep 20.